Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplant for Hepatic Encephalopathy
NCT03420482Phase 2Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2018
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation capsules in hepatic encephalopathy (HE), sponsored by Massachusetts General Hospital. Started Apr 2018; status: active, not recruiting.
02
Drugs
Fecal Microbiota Transplantation capsules
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03420482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420482.